GlobeNewswire

Virtusa Partners with Legerity to Help Put U.S. Veterans on the Front Lines of Digital Process Automation

Share

SOUTHBOROUGH, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS: VRTU) a global provider of digital engineering, strategy, and IT outsourcing to improve client experiences, today announced a partnership with Legerity, a provider of consulting and implementation services, that will help put U.S. Veterans on the front lines of Digital Process Automation (DPA) projects with clients throughout the United States.

This partnership is centered on helping clients in healthcare utilize the advanced Pega platform to implement DPA projects improving member, provider and customer experiences.  Today’s announcement coincides with Pegaworld 19, which is attended by more than 5,000 industry pioneers, influencers, and thought leaders from the world’s leading organizations.

Virtusa, with its deep domain and digital engineering expertise, delivers digital process automation design, build and implementation services at scale. Virtusa has more than 2,500 DPA experts who have delivered DPA implementations to hundreds of clients.

Founded in 2018 by two former senior executives at Anthem, Inc, Jeffrey Schrecengost and Jamisson Fowler, Legerity provides strategic consulting and enablement services.  Legerity’s enablement and staff augmentation services lower costs of implementation but most importantly enable clients to be self-sustaining.  Legerity specializes in hiring and training US Military Veterans.

“Legerity has quickly become a top resource for DPA enablement and strategy,” said Anthony Lange, Senior Vice President, Virtusa. “This partnership will allow Virtusa to focus on our digital engineering expertise and collaborate with Legerity to focus on client enablement and strategy.’

“This partnership with Virtusa is about assuring clients have access to the best available skills during every step of their Digital Process Automation journey,” said Jamisson Fowler, Managing Partner, Legerity. “Our strengths in DPA enablement and Healthcare strategy is the perfect complement to Virtusa’s digital engineering experience and scale.”

To learn more about Virtusa’s Digital Process Automation solutions and capabilities, visit http://www.virtusa.com/perspective-cat/dpa/ 

About Legerity
Legerity is a premier provider of Pega consulting and implementation services. We provide project management, staff augmentation, workforce development, and strategic consulting. Our client-centered staffing services model delivers Pega resources to your organization quickly and efficiently. Reliable, innovative, and personable Pega professionals from Legerity help client companies meet their Pega objectives without the expense and delay of a lengthy recruiting processes.

About Virtusa Corporation
Virtusa Corporation (NASDAQ GS: VRTU) is a global provider of digital business transformation, digital engineering, and information technology (IT) outsourcing services. Using a combination of digital strategy, business implementation, and IT platform modernization services, Virtusa helps clients drive profitable growth and lead market disruption through digital first client experiences. Founded in 1996 and headquartered in Southborough, Mass., Virtusa serves Global 2000 companies in the banking, financial services, insurance, healthcare, telecommunications, media, entertainment, travel, manufacturing and technology industries. For more information, visit www.virtusa.com.
© 2019 Virtusa Corporation.  All rights reserved.

Virtusa, Accelerating Business Outcomes, BPM Test Drive, and Productization are registered trademarks of Virtusa Corporation. All other company and brand names may be trademarks or service marks of their respective holders.

Contact:
Kirsten Paragona
Virtusa
kparagona@virtusa.com
978-434-7319

Ron Favali 
Conversion Marketing
ron@conversionam.com
727-512-4490

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor20.8.2019 17:45:00 CESTPress release

Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor New patent granted in the United States by the USPTO protects the use of lanifibranor for the treatment of fibrotic diseases until June 2035 This patent strengthens the protection of lanifibranor in the United States Daix (France), August 20, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced that the United States Patent and Trademark Office (USPTO) granted a new patent on August 20, 2019 that protects the use of lanifibranor for the treatment of fibrotic diseases until June 2035. This new patent further strenghens Inventiva’s patent portfolio for lanifibranor, the Company’s lead product candidate, in the United States, which already comprised a New Chemical Entity (NCE) patent and a patent protect

PCI Biotech: Invitation to second quarter and first half 2019 results presentation20.8.2019 15:38:00 CESTPress release

Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 28 August, 08:30am – 09:30am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo. The presentation will be held in English and if you wish to attend the presentation, please confirm with an e-mail to post@pcibiotech.com. The presentation will also be a live webcast and can be accessed through www.pcibiotech.com. It will be possible to post questions through the webcast console. The interim report and the presentation will be available on www.newsweb.no and on the company's webpage, www.pcibiotech.com from 07:00am (CEST) on 28 August 2019. For further information, please contact: Ronny Skuggedal, CFO Email: rs@pcibiotech.no Mobile: +47 9400 5757 About PCI Biotech PCI Biotech is a biopharmaceutica

Regarding resignation of member of the Supervisory Board20.8.2019 15:30:00 CESTPress release

We hereby inform that, T. Lukoševičius, a member of Supervisory Board of AB Klaipedos nafta (hereinafter – the Company) 20 August 2019 submitted a notice of resignation of members of Supervisory Board of the Company as of 3 September 2019 (this day is the last day of the mandate). It should be noted that, currently the Supervisory Board of the Company consists of 3 members, 2 of them are independent. After the resignation of T. Lukoševičius, the Ministry of Energy of the Republic of Lithuania will conduct the selection of new member of the Supervisory Board. The Supervisory Board is elected by the General Meeting of Shareholders for 4 years. If individual members of the Supervisory Board are elected, they shall be elected only until the end of the term of office of the current Supervisory Board. Jonas Lenkšas, Chief Financial Officer,+370 694 80594

SERSTECH AB: Boardmember Anna Werntoft resigns from the Board of Serstech20.8.2019 13:40:00 CESTPress release

Anna Werntoft will leave the board of directors effective on the 30th of September. The reason for her resignation is that she enters a new operational position with terms that does not allow external assignments. Serstech wishes Anna all the best in her new position and would like to thank her for her contribution while being on the Serstech Board. The Serstech will consist of three Board members until the vacant position is filled. The search for a replacement has started and will be concluded before the next annual general meeting. For further information, please contact: Stefan Sandor, CEO, Serstech AB tel: +46 739 606067 email: ss@serstech.com Thomas Pileby, Chairman of the Board, Serstech AB tel: +46 702 072643 email: tp@serstech.com Company website: www.serstech.com The information was submitted for publication, through the agency of the contact person set out above at 13:40 CET on August 20, 2019. Certified advisor to Serstech is Västra Hamnen Corporate Finance AB, phone: 040-2